Elevated Pulmonary Artery Wedge Pressure in Group 1 Pulmonary Hypertension
Circulation · 31.03.2026 · 153 (13) · 948-962
DOI: 10.1161/circulationaha.125.077606 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 31.03.2026. Verfasst von Yogesh N V Reddy und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine (Y.N.V.R., R.P.F., W.R.M., R.V., B.A.B.), Mayo Clinic, Rochester, MN. Hauptthemen laut MEDLINE: Pulmonary Wedge Pressure, Hypertension, Pulmonary. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: With pulmonary hypertension (PH), a pulmonary artery wedge pressure (PAWP)>15 mm Hg is used to diagnose left heart dysfunction, but some patients with adjudicated group 1 PH demonstrate PAWP>15 mm Hg. The primary objective of the study was to evaluate group 1 PH with high PAWP>15 mm Hg. METHODS: Patients with adjudicated group 1 PH from PVDOMICS between 2016 and 2019 were separated into high PAWP(>15 mm Hg) or normal PAWP and compared with adjudicated combined pre- and postcapillary (Cpc) PH related to heart failure with preserved ejection fraction (HFpEF). Participants underwent dynamic right heart catheterization and metabolomics. Findings were validated in 3 independent cohorts with adjudicated group 1 PH (validation cohorts 1 and 2 with exercise right heart catheterization and validation cohort 3 with resting right heart catheterization). RESULTS: Of 325 patients with group 1 PH (73% women, mean age 53.0±14.3 years), 15% (n=48) had high PAWP. Group 1 PH+high PAWP demonstrated greater obesity, left ventricular hypertrophy ( P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine (Y.N.V.R., R.P.F., W.R.M., R.V., B.A.B.), Mayo Clinic, Rochester, MN.
- Division of Endocrinology (A.K.A., K.S.N.), Mayo Clinic, Rochester, MN.
- Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Arizona, Tucson, AZ (F.R.).
- Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD (P.M.H., S.C.M., M.M.).
- Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN (A.R.H.).
- Perkin Heart Failure Center, Division of Cardiology, Weill Cornell Medicine, New York, NY (E.H.).
ORCID-Profile: Yogesh N V Reddy, Robert P Frantz, William R Miranda, Aneesh K Asokan, Franz Rischard, Paul M Hassoun, Anna R Hemnes, Evelyn Horn, Jane A Leopold, Erika B Rosenzweig, Nicholas S Hill, Serpil C Erzurum, Gerald J Beck, John Barnard, J Emanuel Finet, Deborah Kwon, Stephen C Mathai, Monica Mukherjee, W H Wilson Tang, Barry A Borlaug
Förderung
- NHLBI NIH HHS
Zitieren
APA
Reddy, Y. N. V., Frantz, R. P., Miranda, W. R., Asokan, A. K., Varma, R., Rischard, F., Hassoun, P. M., Hemnes, A. R., Horn, E., Leopold, J. A., Rosenzweig, E. B., Hill, N. S., Erzurum, S. C., Beck, G. J., Barnard, J., Finet, J. E., Kwon, D., Mathai, S. C., Mukherjee, M., …, & Borlaug, B. A. (2026). Elevated Pulmonary Artery Wedge Pressure in Group 1 Pulmonary Hypertension. Circulation, 153(13), 948-962. https://doi.org/10.1161/circulationaha.125.077606
Vancouver
Reddy YNV, Frantz RP, Miranda WR, Asokan AK, Varma R, Rischard F, et al. Elevated Pulmonary Artery Wedge Pressure in Group 1 Pulmonary Hypertension. Circulation. 2026;153(13):948-962. doi:10.1161/circulationaha.125.077606
BibTeX
@article{Reddy2026,
author = {Reddy, Yogesh N V and Frantz, Robert P and Miranda, William R and Asokan, Aneesh K and Varma, Revati and Rischard, Franz and Hassoun, Paul M and Hemnes, Anna R and Horn, Evelyn and Leopold, Jane A and Rosenzweig, Erika B and Hill, Nicholas S and Erzurum, Serpil C and Beck, Gerald J and Barnard, John and Finet, J Emanuel and Kwon, Deborah and Mathai, Stephen C and Mukherjee, Monica and Tang, W H Wilson and Nair, K Sreekumaran and Borlaug, Barry A},
title = {Elevated Pulmonary Artery Wedge Pressure in Group 1 Pulmonary Hypertension},
journal = {Circulation},
year = {2026},
volume = {153},
number = {13},
pages = {948--962},
doi = {10.1161/circulationaha.125.077606}
}
EUVIMED